Dry Eye

Latest News

Latest Videos

Corticosteroids and Immunomodulators for the treatment of dry eye

Corticosteroids and Immunomodulators for the treatment of dry eye

Review of artificial tears for DED

Review of artificial tears for DED

OD and MD communication for optimal care

OD and MD communication for optimal care

General Principles of Treatment of DED

General Principles of Treatment of DED

Standard testing and assessment for DED

Standard testing and assessment for DED

Diagnosis and overlooking asymptomatic patients with DED

Diagnosis and overlooking asymptomatic patients with DED

Consequences and epidemiology of untreated dry eye

Consequences and epidemiology of untreated dry eye

Introduction and overview

Introduction and overview

S. Wade Kimmell, OD on the importance of updated Glaucoma, OSD and dry eye treatments

S. Wade Kimmell, OD on the importance of updated Glaucoma, OSD and dry eye treatments

Dry Eye Patient (A)

Dry Eye Patient (A)

CME Content

(COPE Track) Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

(COPE Track) Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

Stephen C. Pflugfelder, MD; Cecelia Koetting, OD, FAAO, DipABO

Navigating Ocular Toxicities: A Multidisciplinary Roadmap for Managing Adverse Events in Targeted Cancer Therapy

Navigating Ocular Toxicities: A Multidisciplinary Roadmap for Managing Adverse Events in Targeted Cancer Therapy

Basil Williams, MD; Maura Di Nicola, MD

Rapid Reviews in Retina™: Emerging Updates from Fall 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

Rapid Reviews in Retina™: Emerging Updates from Fall 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

John Kitchens, MD; Michael W. Stewart, MD

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - California

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - California

Dilsher S. Dhoot, MD, FASRS

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - NYC Metro

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - NYC Metro

Deep Parikh, MD

The Presbyopia-Correcting and Toric IOL Playbook: Game-Changing Surgical Strategies to Enhance Patient Outcomes

The Presbyopia-Correcting and Toric IOL Playbook: Game-Changing Surgical Strategies to Enhance Patient Outcomes

Uday Devgan, MD, FACS, FRCS

When Mites Meet Their Match: Empowering Patients With Targeted Treatment for 𝘋𝘦𝘮𝘰𝘥𝘦𝘹 Blepharitis

When Mites Meet Their Match: Empowering Patients With Targeted Treatment for 𝘋𝘦𝘮𝘰𝘥𝘦𝘹 Blepharitis

Mile Brujic, OD, FAAO; Pierce Kenworthy, OD, FAAO; Blair Lonsberry, MS, OD, MEd, FAAO

(COPE) The Truth About Presbyopia Drops: Evidence-Based Cases and Myth-Busting Insights

(COPE) The Truth About Presbyopia Drops: Evidence-Based Cases and Myth-Busting Insights

Damon Dierker, OD FAAO; Maria Pribis, OD

(CME Track) Embracing the Interventional Glaucoma Mindset: A Paradigm Shift in Contemporary Glaucoma Management

(CME Track) Embracing the Interventional Glaucoma Mindset: A Paradigm Shift in Contemporary Glaucoma Management

Mary Qiu, MD; Paul Singh, MD; Danica J. Marrelli, OD, FAAO

(CME Track) Reducing Treatment Burden in Retinal Disease Care With Extended-Duration Anti-VEGF Therapies

(CME Track) Reducing Treatment Burden in Retinal Disease Care With Extended-Duration Anti-VEGF Therapies

John Kitchens, MD

(CME Track) Cutting-Edge Care in Neovascular Retinal Disease: Expert Approaches to Selection and Interval Extension

(CME Track) Cutting-Edge Care in Neovascular Retinal Disease: Expert Approaches to Selection and Interval Extension

Geeta Lalwani, MD; Alla Goldberg, MD; Elite Bor-Shavit, MD

(COPE Track) Next-Generation Solutions for nAMD and DME: Bridging Evidence and Practice Gaps in Disease Management

(COPE Track) Next-Generation Solutions for nAMD and DME: Bridging Evidence and Practice Gaps in Disease Management

Murtaza K. Adam, MD, FASRS; Deepak Sambhara, MD, FASRS; Betty Zhang, OD

(COPE Track) Emerging Therapeutic Advancements in Dry Eye Disease Management

(COPE Track) Emerging Therapeutic Advancements in Dry Eye Disease Management

Rahul Tonk, MD; Jade Coats, OD, FAAO; Aaleya Koreishi, MD; Zeba Syed, MD

(COPE Track) Cutting-Edge Care in Neovascular Retinal Disease: Expert Approaches to Selection and Interval Extension

(COPE Track) Cutting-Edge Care in Neovascular Retinal Disease: Expert Approaches to Selection and Interval Extension

Geeta Lalwani, MD; Alla Goldberg, MD; Elite Bor-Shavit, MD

More News

Podcast: Alliance for Patient Safety chair talks contact lenses and the FTC

ByBrooke Henson, Editor

January 22nd 2021

Dr. Alexander, chair of the Alliance for Patient Safety, discusses recent changes from the FTC on contact lenses.

Understand neuropathic pain treatments

ByTracy Schroeder Swartz, OD, MS, FAAO

January 21st 2021

Blepharitis requires patient education

ByKatherine M. Mastrota, OD, MS, FAAO, DipABO

January 8th 2021

Type and cause of the condition are important to discuss during the examination

How to implement IPL into an optometry practice

ByElise Brisco, OD, FAAO, FCOVD, CCH

January 7th 2021

From choosing a system to picking candidates, the process exceeded expectations

How to handle dry eye follow-up visits

ByTracy Schroeder Swartz, OD, MS, FAAO

December 3rd 2020

Managing ocular surface disease patients depends on symptom severity and treatment choice

Quiz: Know the ocular effects of eyelash growth serums

ByBrooke Henson, Editor

December 2nd 2020

quick quiz

Know the ocular effects of eyelash growth serums

ByTracy Doll, OD, FAAO

December 2nd 2020

Creating longer lashes may lead to clinical concerns

Quiz answers: Know the ocular effects of eyelash growth serums

ByBrooke Henson, Editor

December 2nd 2020

Novel agents in the pipeline for DED

ByBrooke Henson, Editor,Tracy Schroeder Swartz, OD, MS, FAAO,Marguerite McDonald, MD,Eric Donnenfeld, MD,Crystal Brimer, OD, FAAO

November 18th 2020

Agents in the pipeline for DED

ByBrooke Henson, Editor,Tracy Schroeder Swartz, OD, MS, FAAO,Marguerite McDonald, MD,Eric Donnenfeld, MD,Crystal Brimer, OD, FAAO

November 18th 2020

Overlapping diseases and COVID-19's impact

ByBrooke Henson, Editor,Tracy Schroeder Swartz, OD, MS, FAAO,Marguerite McDonald, MD,Eric Donnenfeld, MD,Crystal Brimer, OD, FAAO

November 18th 2020

Counseling and formulary concerns for DED therapies

ByBrooke Henson, Editor,Tracy Schroeder Swartz, OD, MS, FAAO,Marguerite McDonald, MD,Eric Donnenfeld, MD,Crystal Brimer, OD, FAAO

November 18th 2020

Challenges in the management of DED

ByBrooke Henson, Editor,Tracy Schroeder Swartz, OD, MS, FAAO,Marguerite McDonald, MD,Eric Donnenfeld, MD,Crystal Brimer, OD, FAAO

November 18th 2020

Treatments for aqueous dry eye

ByBrooke Henson, Editor,Tracy Schroeder Swartz, OD, MS, FAAO,Marguerite McDonald, MD,Eric Donnenfeld, MD,Crystal Brimer, OD, FAAO

November 18th 2020

Crystal Brimer, OD, FAAO, shares some in-office procedures for dry eye and the patient resistance with high cost.

In-office procedures and patient resistance for DED treatments

ByBrooke Henson, Editor,Tracy Schroeder Swartz, OD, MS, FAAO,Marguerite McDonald, MD,Eric Donnenfeld, MD,Crystal Brimer, OD, FAAO

November 18th 2020

Crystal Brimer, OD, FAAO, identifies the preferred treatment options for meibomian gland dysfunction.

How to treat meibomian gland dysfunction

ByBrooke Henson, Editor,Tracy Schroeder Swartz, OD, MS, FAAO,Marguerite McDonald, MD,Eric Donnenfeld, MD,Crystal Brimer, OD, FAAO

November 18th 2020

Eric Donnenfeld, MD, and Marguerite McDonald, MD, discuss the role of nutritional supplements as well as antibiotics in dry eye management.

The role of nutritional supplements and antibiotics in DED

ByBrooke Henson, Editor,Tracy Schroeder Swartz, OD, MS, FAAO,Marguerite McDonald, MD,Eric Donnenfeld, MD,Crystal Brimer, OD, FAAO

November 18th 2020

Transcript: OD test drives meibographer, shares pros and cons

ByMelanie Denton Dombrowski, OD, MBA, FAAO,Brooke Henson, Editor

November 18th 2020

Video: Optometry Times® news summary 11/15/2020

ByGretchyn M. Bailey, NCLC, FAAO, Editor in Chief, Content Channel Director

November 13th 2020

Optometry news update

Think about the blink: Part 1

ByJill K. Showalter, OD

November 12th 2020

Blink rate and completeness matter most for comfort

Pipeline: New therapies to come for debilitating eye diseases

ByGretchyn M. Bailey, NCLC, FAAO, Editor in Chief, Content Channel Director,Bernard Gilly, PhD

November 12th 2020

New drug from Gensight Biologics hits pipeline

How to identify ptosis in clinical practice

BySusan Resnick, OD, FAAO, FSLS

November 9th 2020

A simple addition to the comprehensive exam can make a big difference for patients

5 communication strategies for dry eye patients

ByKatherine M. Mastrota, OD, MS, FAAO, DipABO

November 8th 2020

Ocular surface disease is chronic, and collaborative care is key to treatment success

2 factors that increase risk of microbial keratitis in contact lens wearers

ByBenjamin P. Casella, OD, FAAO

November 7th 2020

New study looks at patient lifestyle and hygiene risk factors for corneal infection

How one OD incorporates new contact lens technology in his practice

ByDavid Kading, OD, FAAO, FCLSA

November 6th 2020

Will new contact lens technology bring about better patient care?

Trending on Optometry Times - Clinical News & Expert Optometrist Insights

Takeaways from this week in optometry: October 16-23

BIM-IOL System holds 37% IOP reduction at 4 years in first-in-human trial

Brepocitinib for noninfectious uveitis meets all phase 3 trial end points

More than monitoring: Using AMD visits to promote healthy vision aging

The Independent Advantage S02 E07: Is your front desk missing opportunities?